Plain-English translation of NCT06978296 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing stereotactic radiotherapy (a precise, focused form of radiation) for men with advanced prostate cancer that has spread to bones or lymph nodes and stopped responding to standard hormone therapy or chemotherapy. Researchers want to find out how much total tumor volume can safely be treated with this radiation approach at one time. The goal is to help control pain and prevent serious complications like bone fractures or spinal cord pressure.
Many men with advanced prostate cancer develop cancer spread to bones and lymph nodes that no longer responds to standard treatments, causing pain and life-threatening complications. This trial exists to see if targeted radiation therapy can safely treat multiple tumors at once and extend the time patients live without these painful or dangerous complications.
You likely qualify if…
You likely don't qualify if…
You would receive stereotactic radiotherapy (highly focused radiation delivered precisely to tumor sites) with doses and volumes that gradually increase as the study progresses. You would need to attend clinic visits for imaging, treatment planning, and radiation sessions. The research team will monitor you closely during and after treatment to check for side effects and measure whether the treatment reduces pain and prevents serious complications.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France